TELA Bio, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
TELA Bio, Inc. (TELA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.49 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-12
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 14.49M shares, a 0.44% increase year-over-year.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 14.46M shares, a 26.35% increase year-over-year.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 14.44M shares, a 26.58% increase year-over-year.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 14.44M shares, a 133.89% increase year-over-year.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 12.93M shares, a 632.24% increase from fiscal 2019.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 1.77M shares, a 498.81% increase from fiscal 2018.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 294.99K shares, a 1.04% increase from fiscal 2017.
- TELA Bio, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 291.96K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | 14.49M shares 10-Q · filed 2021-11-12 | 14.47M shares derived: average of 2 quarters · filed 2021-11-12 | 14.46M shares 10-Q · filed 2021-11-12 | 14.46M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 14.46M shares 10-Q · filed 2021-08-12 | 14.45M shares 10-Q · filed 2021-08-12 | 14.45M shares derived: average of 3 quarters · filed 2021-08-12 | 14.44M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | 14.44M shares 10-Q · filed 2021-05-14 | 14.44M shares derived: average of 2 quarters · filed 2021-05-14 | 14.43M shares derived: average of 3 quarters · filed 2021-11-12 | 13.69M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | 14.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 14.43M shares derived: average of 2 quarters · filed 2021-11-12 | 13.44M shares derived: average of 3 quarters · filed 2021-11-12 | 12.93M shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 14.42M shares 10-Q · filed 2021-11-12 | 12.93M shares derived: average of 2 quarters · filed 2021-11-12 | 12.43M shares 10-Q · filed 2021-11-12 | 10.86M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | 11.44M shares 10-Q · filed 2021-08-12 | 11.42M shares 10-Q · filed 2021-08-12 | 9.68M shares derived: average of 3 quarters · filed 2021-08-12 | 7.33M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 11.41M shares 10-Q · filed 2021-05-14 | 8.79M shares derived: average of 2 quarters · filed 2021-05-14 | 5.96M shares derived: average of 3 quarters · filed 2021-05-14 | 4.54M shares derived: average of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | 6.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 3.24M shares derived: average of 2 quarters · filed 2021-03-25 | 2.26M shares derived: average of 3 quarters · filed 2021-03-25 | 1.77M shares 10-K · filed 2021-03-25 |
| 2019-09-30 | 297.75K shares 10-Q · filed 2020-11-12 | 297.11K shares derived: average of 2 quarters · filed 2020-11-12 | 296.74K shares 10-Q · filed 2020-11-12 | 296.42K shares derived: average of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | 296.47K shares 10-Q · filed 2020-08-13 | 296.23K shares 10-Q · filed 2020-08-13 | 295.98K shares derived: average of 3 quarters · filed 2021-03-25 | 295.79K shares derived: average of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | 295.99K shares 10-Q · filed 2020-05-15 | 295.74K shares derived: average of 2 quarters · filed 2021-03-25 | 295.57K shares derived: average of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | 295.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 295.36K shares derived: average of 2 quarters · filed 2021-03-25 | 294.99K shares 10-K · filed 2021-03-25 | |
| 2018-09-30 | 295.23K shares 10-Q · filed 2019-12-18 | 294.82K shares 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | 291.96K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |